Retinoblastoma protein potentiates the innate immune response in hepatocytes: Significance for hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retinoblastoma protein potentiates the innate immune response in hepatocytes: Significance for hepatocellular carcinoma

Published:2014-08-28 Issue:4 Volume:60 Page:1231-1240
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hutcheson Jack¹,Bourgo Ryan J.²³,Balaji Uthra¹,Ertel Adam²,Witkiewicz Agnieszka K.¹⁴,Knudsen Erik S.¹⁴

Affiliation:

1. Department of Pathology; University of Texas Southwestern Medical Center; Dallas TX

2. Department of Cancer Biology; Kimmel Cancer Center, Thomas Jefferson University; Philadelphia PA

3. Ben May Department for Cancer Research; University of Chicago; Chicago IL

4. Simmons Cancer Center, University of Texas Southwestern Medical Center; Dallas TX

Funder

National Cancer Institute

Publisher

Wiley

Subject

Hepatology

Reference42 articles.

1. Hitting their targets: an emerging picture of E2F and cell cycle control;Blais;Curr Opin Genet Dev,2004

2. Rb function in cell-cycle regulation and apoptosis;Harbour;Nat Cell Biol,2000

3. Cellular mechanisms of tumour suppression by the retinoblastoma gene;Burkhart;Nat Rev Cancer,2008

4. Tailoring to RB: tumour suppressor status and therapeutic response;Knudsen;Nat Rev Cancer,2008

5. Viral oncoprotein binding to pRB, p107, p130, and p300;Ludlow;Virus Res,1995

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced innate responses in microglia derived from retinoblastoma patient‐specific iPSCs;Glia;2024-01-22

2. Evolving strategies and application of proteins and peptide therapeutics in cancer treatment;Biomedicine & Pharmacotherapy;2023-07

3. RB1 aberrations predict outcomes of immune checkpoint inhibitor combination therapy in NSCLC;Frontiers in Oncology;2023-06-27

4. Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives;Frontiers in Oncology;2023-04-28

5. BET Inhibition Sensitizes Immunologically Cold Rb-Deficient Prostate Cancer to Immune Checkpoint Blockade;Molecular Cancer Therapeutics;2023-04-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3